IMV ROIC
Was ist das ROIC von IMV?
ROIC von IMV, Inc. ist -101.77%
Was ist die Definition von ROIC?
Return on invested capital (ROIC) is a financial ratio that measures how efficient a company is at allocating the capital under its control to profitable investments.
= NOPAT / Invested capital = EBIT * (1 - tax rate) / (2-year average liabilities + 2-year average shareholder equity)
Return on invested capital (ROIC) ratio gives investors a sense of how well a company is using money under its control to generate profitable returns.
ROIC can be used as a benchmark to calculate the valuation of companies across industries. A higher ROIC means the company is doing a better job of investing the money from shareholders and bondholders to run the business. A company is creating value if its ROIC exceeds 2%. If its ROIC is under 2%, the company is likely destroying value and has no excess capital to invest in future growth.
You can calculate ROIC with the following formula:
NOPAT = Net operating profit after tax
Invested Capital = Average total liabilities + Average shareholders' equity
The averages of liabilities and shareholders' equity are calculated as geometrical averages of the last two annual values from the company's balance sheet.
ROIC von Unternehmen in Health Care Sektor auf TSX im Vergleich zu IMV
Was macht IMV?
IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and microsatellite instability high tumors, as well as in Phase I clinical trial for breast cancer. It also develops DPX-SurMAGE that is in Phase I clinical trial for bladder cancer; and DPX-COVID-19 and DPX-RSV for infectious diseases. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.
Unternehmen mit roic ähnlich IMV
- Wrap Technologies hat ROIC von -102.32%
- Arcimoto Inc hat ROIC von -102.30%
- Intelicare hat ROIC von -102.13%
- Bio-Thera Solutions hat ROIC von -102.01%
- ADiTx Therapeutics hat ROIC von -101.90%
- Tenax Therapeutics Inc hat ROIC von -101.88%
- IMV hat ROIC von -101.77%
- Millennial ESports hat ROIC von -101.74%
- FansUnite Entertainment hat ROIC von -101.52%
- Novus Therapeutics Inc hat ROIC von -101.47%
- Avadel Pharmaceuticals plc hat ROIC von -101.45%
- Jupiter Wellness hat ROIC von -101.14%
- Aurora Labs hat ROIC von -101.02%